BeOne Medicines AG 06160.HK 价格预测与展望

Q: 技术分析指标如何适用于 06160.HK？

根据技术分析，BeOne Medicines AG 的综合信号为 Buy。BeOne Medicines AG 有 4 个买入信号，2 个中性信号和 1 个卖出信号。

Q: 06160.HK 的斐波那契回调水平是多少？

BeOne Medicines AG 的斐波那契回调水平是 在 61.8% 和 78.6% 之间。

Q: BeOne Medicines AG 的 RSI 是多少？

BeOne Medicines AG 的 RSI 目前为 51.31，表明处于 中立 状态

Q: BeOne Medicines AG 接下来 12 个月的价格是多少？

BeOne Medicines AG 06160.HK 接下来 12 个月的价格预计为 $0。

Q: BeOne Medicines AG 预计会涨到多高？

据华尔街分析师称，BeOne Medicines AG 预计将达到 $0 的高预测值。

主页

股票

06160.HK

预测

BEONE MEDICINES (06160.HK)

BeOne Medicines AG

HK$200

休市： Jan 21, 16:00:00 HKT

360

报告

A+

最终得分

关键数据

前收盘价

$198.7

开盘价

$200

当日区间

$198.3 - $202.4

52周范围

$103.1 - $229.4

交易量

1.9M

平均成交量

3.8M

每股收益（TTM）

0.31

股息收益率

市值

$264.6B

什么是 BEONE MEDICINES？

BeOne Medicines AG is a CH-based company operating in Biotechnology industry. The company is headquartered in Basel, Basel-Stadt and currently employs 11,075 full-time employees. The company went IPO on 2016-03-02. BeOne Medicines AG, formerly BeiGene, Ltd., is a global oncology company engaged in discovering and developing treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, the Company is engaged in the development of its diverse pipeline of novel therapeutics. Its products include Brukinsa, Tevimbra and Pamiparib. Brukinsa is an orally available, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Tevimbra is a humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. The company is designed to minimize binding to Fc-gamma (Fcy) receptors on macrophages, helping the body’s immune cells detect and fight tumors. The Company’s product pipeline in development includes Sonrotoclax, Tarlatamab, Zanidatamab, Blinatumomab, BGB-26808, BGB-R046, BG-68501, BG-C9074, BGB-43395, Xaluritamig, and others.

功能特性

交易策略

资源

市场

06160.HK 股价预测摘要

06160.HK stock price ended at $198.7 on 星期二, after dropping 0.85%

On the latest trading day Jan 20, 2026, the stock price of 06160.HK fell by 0.85%, dropping from $200.00 to $198.70. During the session, the stock saw a volatility of 1.73%, with prices oscillating between a daily low of $197.00 and a high of $200.40. On the latest trading day, the trading volume for 06160.HK decreased by 303.6K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 2.1M shares were traded, with a market value of approximately $262.9B.

06160.HK 技术面信号

技术面信号摘要

购买信号 4

中性信号 2

卖出信号 1

Strong Sell

Sell

Neutral

Buy

Strong Buy

06160.HK目前显示4个买入信号和1个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-3.36%。总体而言，技术指标显示中期前景为Buy。

06160.HK 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 06160.HK 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 06160.HK？



06160.HK 的斐波那契回调水平是多少？



BeOne Medicines AG 的 RSI 是多少？



BeOne Medicines AG 接下来 12 个月的价格是多少？



BeOne Medicines AG 预计会涨到多高？



BeOne Medicines AG（06160.HK）价格

06160.HK 股价走势图